← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$3.4M

Shares

85,163

Price

$40

Filed

Apr 10

Insider

Name

Knight Jeff E.

Title

Chief Dev. & Operating Officer

CIK

0001881007

Roles

Officer

Transaction Details

Transaction Date

2026-04-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

105,289

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $40.10 per share. The range of sale prices on the transaction date was $40.00 to $40.34. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | 25% of the shares subject to the option vested on August 30, 2022, and the remaining number of shares subject to the option vested monthly thereafter in thirty-six equal installments. | 1/48th of the shares subject to the option vested monthly measured from the vesting commencement date of February 28, 2022. | The option is exercisable as follows: 1/48th of the shares subject to the option vest monthly measured from the vesting commencement date of March 1, 2023, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Filing Info

Accession No.

0001628280-26-024716

Form Type

4

Issuer CIK

0001658247

Knight Jeff E.'s History

Date Ticker Type Value
2026-04-16 ALXO A $0
2026-04-08 CRNX M $1.2M
2026-04-08 CRNX M $193K
2026-04-08 CRNX M $380K
2026-04-08 CRNX $3.4M
2026-04-08 CRNX M $0
2026-04-08 CRNX M $0
2026-04-08 CRNX M $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
2026-04-08